474 Results (Page 8 of 19)
Egypt Markets Research Reports
Egypt Depression/Major Depressive Disorders (MDD) Market Analysis
Egypt Depression/Major Depressive Disorders (MDD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving the Depression/Major Depressive Disorders (MDD) market include rising global depression prevalence, increased awareness and understanding of mental health issues, advancements in treatment options such as new medications and therapies, rising healthcare expenditure and insurance coverage for mental health, and government initiatives aimed at improving mental healthcare access. Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bristol Myers Squibb Company, H. Lundbeck A/S, Merck & Co., Inc., Allergan plc are global key players in Depression/Major Depressive Disorders (MDD) Market.
Egypt Diabetes Management Market Analysis
Egypt Diabetes Management Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Diabetes management market drivers include rising diabetes prevalence, technological advancements in glucose monitoring and insulin delivery systems, increased diabetes awareness and education, government initiatives promoting diabetes management, and rising healthcare expenditure on chronic disease management. Medtronic plc, Abbott Laboratories, Dexcom, Roche Diabetes Care, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Company are global key players in Diabetes Management Market.
Egypt Diabetic Retinopathy Drugs Market Analysis
Egypt Diabetic Retinopathy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of diabetic retinopathy, technological advancements in drug development, growing awareness and screening programmes, the ageing population, and government initiatives to improve access to screening and treatment for diabetic retinopathy are the drivers of the Diabetic Retinopathy Drugs market. Novartis AG, Regeneron Pharmaceuticals, Allergan plc (part of AbbVie Inc.), Roche Holding AG, Pfizer Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alimera Sciences, are key global companies in diabetic retinopathy drugs market.
Egypt Diabetic Retinopathy Therapeutic Market Analysis
Egypt Diabetic Retinopathy Therapeutic Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of diabetes, growing awareness and early diagnosis, advancements in technology and treatment options, government initiatives and healthcare expenditure, and the aging population are the drivers of the diabetic retinopathy therapeutic market. Prominent global players in the market include Novartis AG, Roche Holdings AG, Regeneron Pharmaceuticals, Bayer AG, Allergan plc (AbbVie Inc.), Alimera Sciences, Bausch Health Companies Inc., Topcon Corporation, Carl Zeiss Meditec AG and NIDEK Co., Ltd.
Egypt Drugs Addiction Market Analysis
Egypt Drugs Addiction Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drug addiction market is driven by rising substance usage, increased awareness and public health campaigns, breakthroughs in treatment methods, government initiatives and legislation, and the high frequency of co-occurring mental health issues. Indivior PLC, Alkermes plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Orexo AB, Mylan N.V., Glenmark Pharmaceuticals, Accord Healthcare Ltd., and Camurus AB are global players in the Drug Addiction Market.
Egypt Dry Eye Medication Market Analysis
Egypt Dry Eye Medication Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of dry eye, aging population, technological advancements in drug formulations and diagnostics, rising awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution are the drivers of the dry eye medication market. Allergan plc (AbbVie Inc.), Novartis AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alcon, Inc. (a division of Novartis AG), Sun Pharmaceutical Industries Ltd., Otsuka Holdings Co., Taisho Pharmaceutical Co., Ltd, Senju Pharmaceutical Co. Are global companies in Dry Eye Medication Market.
Egypt Encephalitis Vaccines Market Analysis
Egypt Encephalitis Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of encephalitis, growing awareness and immunization programs, technological advancements in vaccine development, global travel and migration, and government support and funding are the drivers of the encephalitis vaccines market. GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Merck & Co., Novartis AG, Bharat Biotech International Ltd., Takeda Pharmaceutical Company Limited, Biological E. Limited, Valneva SE and Sinovac Biotech Ltd are global companies in encephalitis vaccines market.
Egypt End-stage Renal Disease(ESRD) Market Analysis
Egypt End-stage renal disease (ESRD) Market Analysis is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the End-stage renal disease (ESRD) market include the increasing prevalence of chronic kidney diseases, advancements in renal replacement therapies, growing demand for kidney transplantation, government initiatives and healthcare policies supporting renal care, and the aging population. Global Players in the ESRD Market are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd., Medtronic plc, Terumo Corporation and Rockwell Medical, Inc.
Egypt Endometriosis Drugs Market Analysis
Egypt Endometriosis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the Endometriosis Drugs market include the increasing prevalence of endometriosis, growing awareness and diagnosis, demand for effective pain management, technological advancements in drug development, and supportive government initiatives. These factors contribute to market growth by addressing unmet needs and improving access to treatment options for endometriosis patients. Global Players in the Endometriosis Drugs Market are AbbVie Inc., Pfizer Inc., Bayer AG, Eli Lilly and Company, Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Teva Pharmaceutical Industries Ltd., Merck & Co. and Takeda Pharmaceutical Company Limited.
Egypt Enzymatic Wound Debridement Market Analysis
Egypt Enzymatic Wound Debridement Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growing prevalence of chronic wounds and diabetic ulcers, Advancements in enzymatic debridement technology, increasing demand for non-invasive and painless wound debridement methods and rising geriatric population prone to chronic wounds are drivers in Enzymatic Wound Debridement Market. Global Companies in the Enzymatic Wound Debridement Market are Smith & Nephew plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Paul Hartmann AG, Hollister Incorporated, Integra LifeSciences Corporation, Organogenesis Inc. and Misonix Inc.
Egypt Enzyme Inhibitors Market Analysis
Egypt Enzyme Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing prevalence of enzyme-related disorders, advances in drug discovery and development, a greater emphasis on personalized therapy, and increased research spending and collaborations are driving the enzyme inhibitors market. Novartis International AG, Roche Holding AG, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi S.A., Boehringer Ingelheim International GmbH, Bayer AG, Takeda Pharmaceutical Company Limited, AbbVie Inc., and Merck KGaA are the global participants in the enzyme inhibitors market.
Egypt Epigenetics Market Analysis
Egypt Epigenetics Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving this market growth include an increase in the incidences of infectious diseases, cancer, chronic conditions, and genetic conditions; rising healthcare spending, which, according to the American Medical Association, will exceed $187.6 billion in 2021; and growing interest in bioinformatics, the market for which will reach $10 billion in revenue in 2022. Global key players in the epigenetics market include Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Merck KGaA, and Abcam plc.
Egypt Epilepsy Drugs Market Analysis
Egypt Epilepsy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of epilepsy, increasing incidences of brain cancer in the geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the market. Some of the prominent global players in the epilepsy drugs market include Pfizer Inc., UCB S.A., GlaxoSmithKline plc, Novartis AG, and Eisai Co., Ltd.
Egypt Gastroesophageal Reflux Disease (GERD) Drugs Market Analysis
Egypt Gastroesophageal Reflux Disease (GERD) Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The high prevalence of GERD, rising awareness and diagnostic rates, technology improvements, and lifestyle variables are all driving factors in the Gastroesophageal Reflux Disease (GERD) medications market. Some prominent global players in the Gastroesophageal Reflux Disease (GERD) drugs market include AstraZeneca PLC, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., Mylan N.V., Perrigo Company plc, and Sun Pharmaceutical Industries Ltd.
Egypt Gastrointestinal Drugs Market Analysis
Egypt Gastrointestinal Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of gastrointestinal problems, caused by factors such as changing lifestyles, dietary habits, and an ageing population, is one of the main drivers for gastrointestinal medications. Technological advances in drug research and targeted medicines, which provide more effective treatment alternatives, also contribute to market growth. Furthermore, as people become more aware of and diagnose gastrointestinal diseases, the need for medications to treat these conditions grows. Pfizer Inc., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., and Allergan plc are among the major global competitors in the gastrointestinal drugs market.
Egypt Generic and Biosimilar Pharmaceutical Market Analysis
Egypt Generic and Biosimilar Pharmaceutical Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The generic and biosimilar pharmaceutical market is driven by cost-effectiveness, patent expirations, rising healthcare demand, and government cost-cutting initiatives. Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH (Novartis), Pfizer Inc., Amgen Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Celltrion Inc., and Stada Arzneimittel AG are global companies in the Generic and Biosimilar Pharmaceutical Market.
Egypt Glaucoma Drugs Market Analysis
Egypt Glaucoma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of glaucoma, caused by factors such as an ageing population and rising awareness, is a driver of the glaucoma medications industry. Drug delivery system technological improvements help to increase treatment choices. Novartis AG, Pfizer Inc., Santen Pharmaceutical Co., Allergan (AbbVie Inc.), Bausch Health Companies Inc., Alcon (a part of Novartis AG), Merck & Co., Aerie Pharmaceuticals, Sun Pharmaceutical Industries Ltd., and Santen Inc. are the global players in the Glaucoma Drugs Market.
Egypt Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market Analysis
Egypt Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the GLP-1 receptor agonist market include their efficacy in controlling blood sugar levels, additional benefits like weight loss and cardiovascular risk reduction, rising prevalence of type 2 diabetes, and increasing awareness of diabetes management, leading to growing demand for these medications. Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH and Zealand Pharma A/S are global key players in the market.
Egypt Glucaric Acid Market Analysis
Egypt Glucaric Acid Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the glucaric acid market include the growing demand in various industries, driven by its applications and eco-friendly properties, increased consumer awareness of sustainability, and ongoing research and development efforts to explore new applications and production methods for glucaric acid. Global Players in Glucaric Acid Market are Rennovia Inc., Rivertop Renewables, Haihang Industry Co., Hebei Long Hai Import and Export Trade Co., Haihang Industry (Jinan) Co., Alfa Chemistry, Tokyo Chemical Industry Co., AK Scientific and Biosynth Carbosynth.
Egypt Glutathione Market Analysis
Egypt Glutathione Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of chronic diseases, demand in the cosmetics and beauty industry, and sports nutrition and performance enhancement are key drivers of the glutathione market. Kyowa Hakko Bio Co., Shandong Jincheng Biological Pharmaceutical Co., Kohjin Life Sciences, NOW Health Group, Merck KGaA, Kaiping Genuine Biochemical Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shenzhen GSH Bio-Technology Co., Energetic Nutrition, and TCI Chemicals are the global players in the glutathione market.
Egypt Gram Positive Bacterial Infections Market Analysis
Egypt Gram Positive Bacterial Infections Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gram-positive bacterial infections market include the increasing prevalence of these infections, the emergence of antibiotic resistance, technological advancements in diagnostics and treatments, and the growing healthcare infrastructure, leading to higher demand for effective treatments and the need for innovative solutions to combat these infections. Global Players in Gram positive Bacterial Infections market are Pfizer Inc., Merck & Co., GlaxoSmithKline, Novartis AG, Sanofi S.A., Johnson & Johnson Services, AbbVie Inc., Bayer AG, AstraZeneca plc and Eli Lilly and Company.
Egypt Gynecology Drugs Market Analysis
Egypt Gynecology Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gynecology drugs market include the increasing prevalence of gynecological disorders, growing awareness and focus on women's health, technological advancements, and supportive government initiatives promoting women's healthcare. Key Global Players in Gynecology Drugs Market are Bayer AG, Pfizer Inc., Merck & Co., Novartis AG, Johnson & Johnson, AbbVie Inc., Allergan plc, Eli Lilly and Company, AstraZeneca plc and GlaxoSmithKline plc.
Egypt H1N1 Vaccines Market Analysis
Egypt H1N1 Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the H1N1 vaccines market include global outbreaks and pandemics, government initiatives and vaccination programs, increasing awareness, and advancements in vaccine development and production. Key global players in H1N1 vaccines market are Sanofi Pasteur, GlaxoSmithKline plc, Seqirus (a subsidiary of CSL Limited), AstraZeneca plc, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Changchun BCHT Biotechnology Co., Serum Institute of India Pvt. Ltd., Daiichi Sankyo Company, and Novartis AG.
Egypt Haematology Market Analysis
Egypt Haematology Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing frequency of blood disorders, technological improvements, the growing elderly population, and increased desire for customised medicine and focused therapies are key drivers of the haematology market. Abbott Laboratories, Sysmex Corporation, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter), HORIBA Ltd., Ortho Clinical Diagnostics, and Agilent Technologies are the global players in the haematology market.
Egypt Hangover Rehydration Supplements Market Analysis
Egypt Hangover Rehydration Supplements Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing ageing population and prevalence of chronic diseases, breakthroughs in medication discovery and technology, and increased access to healthcare in emerging economies are all key drivers of the Hangover Rehydration Supplements Market. Gatorade (PepsiCo), Pedialyte (Abbott Laboratories), Liquid IV, Flyby, Blowfish for Hangovers, Cheers Health Inc., Bytox, Morning Recovery, Resync Recovery Blend, and Hydrant are the global key players in the Hangover Rehydration Supplements Market.